Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 1909

1.

The Impact of Immunonutritional and Physical Status on Surgical Outcome After Pancreaticoduodenectomy in Elderly Patients.

Sugimachi K, Iguchi T, Mano Y, Nishijima T, Nakanoko T, Uehara H, Sugiyama M, Ohta M, Ikebe M, Morita M, Toh Y.

Anticancer Res. 2019 Nov;39(11):6347-6353. doi: 10.21873/anticanres.13846.

PMID:
31704866
2.

The evolution of surgical treatment for gastrointestinal cancers.

Maehara Y, Soejima Y, Yoshizumi T, Kawahara N, Oki E, Saeki H, Akahoshi T, Ikegami T, Yamashita YI, Furuyama T, Sugimachi K, Harada N, Tagawa T, Harimoto N, Itoh S, Sonoda H, Ando K, Nakashima Y, Nagao Y, Yamashita N, Kasagi Y, Yukaya T, Kurihara T, Tsutsumi R, Takamori S, Sasaki S, Ikeda T, Yonemitsu Y, Fukuhara T, Kitao H, Iimori M, Kataoka Y, Wakasa T, Suzuki M, Teraishi K, Yoshida Y, Mori M.

Int J Clin Oncol. 2019 Nov;24(11):1333-1349. doi: 10.1007/s10147-019-01499-7. Epub 2019 Sep 14.

PMID:
31522313
3.

Plastin3 is associated with epithelial-mesenchymal transition and poor prognosis in gastric cancer.

Kurashige J, Yokobori T, Mima K, Sawada G, Takahashi Y, Ueo H, Takano Y, Matsumura T, Uchi R, Eguchi H, Sudo T, Sugimachi K, Mori M, Baba H, Mimori K.

Oncol Lett. 2019 Feb;17(2):2393-2399. doi: 10.3892/ol.2018.9819. Epub 2018 Dec 11.

4.

Serial mutational tracking in surgically resected locally advanced colorectal cancer with neoadjuvant chemotherapy.

Sugimachi K, Sakimura S, Kuramitsu S, Hirata H, Niida A, Iguchi T, Eguchi H, Masuda T, Morita M, Toh Y, Maehara Y, Suzuki Y, Mimori K.

Br J Cancer. 2018 Aug;119(4):419-423. doi: 10.1038/s41416-018-0208-5. Epub 2018 Aug 3.

5.

Prognostic Significance of Preoperative Controlling Nutritional Status (CONUT) Score in Patients Undergoing Hepatic Resection for Hepatocellular Carcinoma: A Multi-institutional Study.

Harimoto N, Yoshizumi T, Inokuchi S, Itoh S, Adachi E, Ikeda Y, Uchiyama H, Utsunomiya T, Kajiyama K, Kimura K, Kishihara F, Sugimachi K, Tsujita E, Ninomiya M, Fukuzawa K, Maeda T, Shirabe K, Maehara Y.

Ann Surg Oncol. 2018 Oct;25(11):3316-3323. doi: 10.1245/s10434-018-6672-6. Epub 2018 Jul 26.

PMID:
30051372
6.

A temporal shift of the evolutionary principle shaping intratumor heterogeneity in colorectal cancer.

Saito T, Niida A, Uchi R, Hirata H, Komatsu H, Sakimura S, Hayashi S, Nambara S, Kuroda Y, Ito S, Eguchi H, Masuda T, Sugimachi K, Tobo T, Nishida H, Daa T, Chiba K, Shiraishi Y, Yoshizato T, Kodama M, Okimoto T, Mizukami K, Ogawa R, Okamoto K, Shuto M, Fukuda K, Matsui Y, Shimamura T, Hasegawa T, Doki Y, Nagayama S, Yamada K, Kato M, Shibata T, Mori M, Aburatani H, Murakami K, Suzuki Y, Ogawa S, Miyano S, Mimori K.

Nat Commun. 2018 Jul 23;9(1):2884. doi: 10.1038/s41467-018-05226-0.

7.

Identification of UHRF2 as a Negative Regulator of Epithelial-Mesenchymal Transition and Its Clinical Significance in Esophageal Squamous Cell Carcinoma.

Iguchi T, Ueda M, Masuda T, Nambara S, Kidogami S, Komatsu H, Sato K, Tobo T, Ogawa Y, Hu Q, Saito T, Hirata H, Sakimura S, Uchi R, Hayashi N, Ito S, Eguchi H, Sugimachi K, Maehara Y, Mimori K.

Oncology. 2018;95(3):179-187. doi: 10.1159/000488860. Epub 2018 Jun 15.

PMID:
29909415
8.

Clinicopathological characteristics of disseminated carcinomatosis of the bone marrow in breast cancer patients.

Shinden Y, Sugimachi K, Tanaka F, Fujiyoshi K, Kijima Y, Natsugoe S, Mimori K.

Mol Clin Oncol. 2018 Jan;8(1):93-98. doi: 10.3892/mco.2017.1502. Epub 2017 Nov 15.

9.

Subtotal Cholecystectomy as a Last Resort for Complicated Gallstone Disease.

Sugimachi K, Iguchi T, Morita M, Toh Y.

J Am Coll Surg. 2018 Feb;226(2):201-202. doi: 10.1016/j.jamcollsurg.2017.10.011. No abstract available.

PMID:
29389376
10.

Antitumor effects of the antiparasitic agent ivermectin via inhibition of Yes-associated protein 1 expression in gastric cancer.

Nambara S, Masuda T, Nishio M, Kuramitsu S, Tobo T, Ogawa Y, Hu Q, Iguchi T, Kuroda Y, Ito S, Eguchi H, Sugimachi K, Saeki H, Oki E, Maehara Y, Suzuki A, Mimori K.

Oncotarget. 2017 Nov 21;8(64):107666-107677. doi: 10.18632/oncotarget.22587. eCollection 2017 Dec 8.

11.

[Analysis of Advanced or Postoperative Recurrent Non-small Lung Cancer Cases Treated with Nivolumab].

Ichiki Y, Iwanami T, Kakizoe K, Hamatsu T, Suehiro T, Yoneda K, Tanaka F, Sugimachi K.

J UOEH. 2017;39(4):291-297. doi: 10.7888/juoeh.39.291. Japanese.

12.

Japanese genome-wide association study identifies a significant colorectal cancer susceptibility locus at chromosome 10p14.

Takahashi Y, Sugimachi K, Yamamoto K, Niida A, Shimamura T, Sato T, Watanabe M, Tanaka J, Kudo S, Sugihara K, Hase K, Kusunoki M, Yamada K, Shimada Y, Moriya Y, Suzuki Y, Miyano S, Mori M, Mimori K.

Cancer Sci. 2017 Nov;108(11):2239-2247. doi: 10.1111/cas.13391. Epub 2017 Sep 26.

13.

Clinical significance of ZNF750 gene expression, a novel tumor suppressor gene, in esophageal squamous cell carcinoma.

Nambara S, Masuda T, Tobo T, Kidogami S, Komatsu H, Sugimachi K, Saeki H, Oki E, Maehara Y, Mimori K.

Oncol Lett. 2017 Aug;14(2):1795-1801. doi: 10.3892/ol.2017.6341. Epub 2017 Jun 8.

14.

A rare anomaly of the right superior pulmonary vein: Report of a case.

Ichiki Y, Kakizoe K, Hamatsu T, Suehiro T, Koike M, Tanaka F, Sugimachi K.

Int J Surg Case Rep. 2017;38:26-28. doi: 10.1016/j.ijscr.2017.05.035. Epub 2017 Jul 6.

15.

Correction: Integrated Multiregional Analysis Proposing a New Model of Colorectal Cancer Evolution.

Uchi R, Takahashi Y, Niida A, Shimamura T, Hirata H, Sugimachi K, Sawada G, Iwaya T, Kurashige J, Shinden Y, Iguchi T, Eguchi H, Chiba K, Shiraishi Y, Nagae G, Yoshida K, Nagata Y, Haeno H, Yamamoto H, Ishii H, Doki Y, Iinuma H, Sasaki S, Nagayama S, Yamada K, Yachida S, Kato M, Shibata T, Oki E, Saeki H, Shirabe K, Oda Y, Maehara Y, Komune S, Mori M, Suzuki Y, Yamamoto K, Aburatani H, Ogawa S, Miyano S, Mimori K.

PLoS Genet. 2017 May 19;13(5):e1006798. doi: 10.1371/journal.pgen.1006798. eCollection 2017 May.

16.

Left hepatectomy with simultaneous hepatic artery and portal vein reconstructions in the operation for cholangiocarcinoma: the surgical techniques comprised of step-by-step established procedures.

Uchiyama H, Shirabe K, Araki K, Sugimachi K, Morita K, Takenaka K, Maehara Y.

Transl Gastroenterol Hepatol. 2017 Apr 28;2:34. doi: 10.21037/tgh.2017.03.16. eCollection 2017.

17.

Up-regulation of SLC9A9 Promotes Cancer Progression and Is Involved in Poor Prognosis in Colorectal Cancer.

Ueda M, Iguchi T, Masuda T, Komatsu H, Nambara S, Sakimura S, Hirata H, Uchi R, Eguchi H, Ito S, Sugimachi K, Mizushima T, Doki Y, Mori M, Mimori K.

Anticancer Res. 2017 May;37(5):2255-2263.

PMID:
28476790
18.

Altered Expression of Hippo Signaling Pathway Molecules in Intrahepatic Cholangiocarcinoma.

Sugimachi K, Nishio M, Aishima S, Kuroda Y, Iguchi T, Komatsu H, Hirata H, Sakimura S, Eguchi H, Bekki Y, Takenaka K, Maehara Y, Suzuki A, Mimori K.

Oncology. 2017;93(1):67-74. doi: 10.1159/000463390. Epub 2017 Apr 28.

PMID:
28448997
19.

Post-hepatectomy Refractory Ascites in Cirrhotic Patients with Hepatocellular Carcinoma: Risk Factor Analysis to Overcome this Problematic Complication.

Itoh S, Uchiyama H, Ikeda Y, Morita K, Harada N, Sugimachi K, Kawanaka H, Korenaga D, Yoshizumi T, Takenaka K, Maehara Y.

Anticancer Res. 2017 Mar;37(3):1381-1385.

PMID:
28314307
20.

Clinical Significance of FANCD2 Gene Expression and its Association with Tumor Progression in Hepatocellular Carcinoma.

Komatsu H, Masuda T, Iguchi T, Nambara S, Sato K, Hu Q, Hirata H, Ito S, Eguchi H, Sugimachi K, Eguchi H, Doki Y, Mori M, Mimori K.

Anticancer Res. 2017 Mar;37(3):1083-1090.

PMID:
28314268
21.

A case of monozygotic twins with primary aldosteronism: a case report.

Yoshida T, Uchiwa Y, Sugimachi K, Naruse M.

J Hum Hypertens. 2017 Jun;31(6):422-423. doi: 10.1038/jhh.2016.91. Epub 2017 Feb 2. No abstract available.

PMID:
28150818
22.

Solitary fibrous tumor of the lung: a case report.

Ichiki Y, Kakizoe K, Hamatsu T, Matsuyama A, Suehiro T, Tanaka F, Hisaoka M, Sugimachi K.

Surg Case Rep. 2017 Dec;3(1):10. doi: 10.1186/s40792-016-0286-7. Epub 2017 Jan 7.

23.

Phase II trial of capecitabine plus modified cisplatin (mXP) as first-line therapy in Japanese patients with metastatic gastric cancer (KSCC1104).

Satake H, Iwatsuki M, Uenosono Y, Shiraishi T, Tanioka H, Saeki H, Sugimachi K, Kitagawa D, Shimokawa M, Oki E, Emi Y, Kakeji Y, Tsuji A, Akagi Y, Natsugoe S, Baba H, Maehara Y; Kyushu Study Group of Clinical Cancer.

Cancer Chemother Pharmacol. 2017 Jan;79(1):147-153. doi: 10.1007/s00280-016-3204-6. Epub 2016 Dec 10.

24.

miR-146a Polymorphism (rs2910164) Predicts Colorectal Cancer Patients' Susceptibility to Liver Metastasis.

Iguchi T, Nambara S, Masuda T, Komatsu H, Ueda M, Kidogami S, Ogawa Y, Hu Q, Sato K, Saito T, Hirata H, Sakimura S, Uchi R, Hayashi N, Ito S, Eguchi H, Sugimachi K, Maehara Y, Mimori K.

PLoS One. 2016 Nov 8;11(11):e0165912. doi: 10.1371/journal.pone.0165912. eCollection 2016.

25.

[WHAT COULD I ACHIEVE DURING MY TERM OF PROFESSORSHIP]?

Sugimachi K.

Nihon Geka Gakkai Zasshi. 2016 Nov;117(6):475-7. Japanese. No abstract available.

PMID:
30173467
26.

Attenuated RND1 Expression Confers Malignant Phenotype and Predicts Poor Prognosis in Hepatocellular Carcinoma.

Komatsu H, Iguchi T, Masuda T, Hirata H, Ueda M, Kidogami S, Ogawa Y, Sato K, Hu Q, Nambara S, Saito T, Sakimura S, Uchi R, Ito S, Eguchi H, Sugimachi K, Eguchi H, Doki Y, Mori M, Mimori K.

Ann Surg Oncol. 2017 Mar;24(3):850-859. doi: 10.1245/s10434-016-5573-9. Epub 2016 Oct 21.

PMID:
27770342
27.

Somatic mutations in plasma cell-free DNA are diagnostic markers for esophageal squamous cell carcinoma recurrence.

Ueda M, Iguchi T, Masuda T, Nakahara Y, Hirata H, Uchi R, Niida A, Momose K, Sakimura S, Chiba K, Eguchi H, Ito S, Sugimachi K, Yamasaki M, Suzuki Y, Miyano S, Doki Y, Mori M, Mimori K.

Oncotarget. 2016 Sep 20;7(38):62280-62291. doi: 10.18632/oncotarget.11409.

28.

Multimodalities Are Useful for Secondary Treatment of Local Bleeding During Hepatic Resection.

Sugimachi K, Morita K, Takenaka K.

J Am Coll Surg. 2016 Aug;223(2):419. doi: 10.1016/j.jamcollsurg.2016.04.039. No abstract available.

PMID:
27456248
29.

8q24 Polymorphisms and Diabetes Mellitus Regulate Apolipoprotein A-IV in Colorectal Carcinogenesis.

Sugimachi K, Yamaguchi R, Eguchi H, Ueda M, Niida A, Sakimura S, Hirata H, Uchi R, Shinden Y, Iguchi T, Morita K, Yamamoto K, Miyano S, Mori M, Maehara Y, Mimori K.

Ann Surg Oncol. 2016 Aug;23(Suppl 4):546-551. Epub 2016 Jul 7.

PMID:
27387680
30.

Rapid diagnosis of lymph node metastasis in breast cancer using a new fluorescent method with γ-glutamyl hydroxymethyl rhodamine green.

Shinden Y, Ueo H, Tobo T, Gamachi A, Utou M, Komatsu H, Nambara S, Saito T, Ueda M, Hirata H, Sakimura S, Takano Y, Uchi R, Kurashige J, Akiyoshi S, Iguchi T, Eguchi H, Sugimachi K, Kubota Y, Kai Y, Shibuta K, Kijima Y, Yoshinaka H, Natsugoe S, Mori M, Maehara Y, Sakabe M, Kamiya M, Kakareka JW, Pohida TJ, Choyke PL, Kobayashi H, Ueo H, Urano Y, Mimori K.

Sci Rep. 2016 Jun 9;6:27525. doi: 10.1038/srep27525.

31.

HOXB7 Expression is a Novel Biomarker for Long-term Prognosis After Resection of Hepatocellular Carcinoma.

Komatsu H, Iguchi T, Masuda T, Ueda M, Kidogami S, Ogawa Y, Nambara S, Sato K, Hu Q, Saito T, Hirata H, Sakimura S, Uchi R, Hayashi N, Ito S, Eguchi H, Sugimachi K, Eguchi H, Doki Y, Mori M, Mimori K.

Anticancer Res. 2016 Jun;36(6):2767-73.

PMID:
27272787
32.

Aberrant Methylation of FOXE1 Contributes to a Poor Prognosis for Patients with Colorectal Cancer.

Sugimachi K, Matsumura T, Shimamura T, Hirata H, Uchi R, Ueda M, Sakimura S, Iguchi T, Eguchi H, Masuda T, Morita K, Takenaka K, Maehara Y, Mori M, Mimori K.

Ann Surg Oncol. 2016 Nov;23(12):3948-3955. Epub 2016 Jun 6.

PMID:
27271927
33.

A primary cellular fibrohistiocytoma of the lung: Report of a case.

Ichiki Y, Kawasaki J, Hamatsu T, Suehiro T, Tanaka F, Hisaoka M, Sugimachi K.

Int J Surg Case Rep. 2016;24:150-2. doi: 10.1016/j.ijscr.2016.05.011. Epub 2016 May 11.

34.

A rare pulmonary hamartoma: fibroleiomyomatous hamartoma.

Ichiki Y, Kawasaki J, Hamatsu T, Suehiro T, Shibuya R, Matsuyama A, Tanaka F, Hisaoka M, Sugimachi K.

Surg Case Rep. 2016 Dec;2(1):53. doi: 10.1186/s40792-016-0184-z. Epub 2016 Jun 2.

35.

Decreased Expression of Fructose-1,6-bisphosphatase Associates with Glucose Metabolism and Tumor Progression in Hepatocellular Carcinoma.

Hirata H, Sugimachi K, Komatsu H, Ueda M, Masuda T, Uchi R, Sakimura S, Nambara S, Saito T, Shinden Y, Iguchi T, Eguchi H, Ito S, Terashima K, Sakamoto K, Hirakawa M, Honda H, Mimori K.

Cancer Res. 2016 Jun 1;76(11):3265-76. doi: 10.1158/0008-5472.CAN-15-2601. Epub 2016 Apr 6.

36.

Surgical Results of Pancreaticoduodenectomy for Pancreatic Ductal Adenocarcinoma: a Multi-institutional Retrospective Study of 174 patients.

Yamashita Y, Yoshizumi T, Fukuzawa K, Nishizaki T, Tsujita E, Kajiyama K, Soejima Y, Yamagata M, Yamamoto K, Adachi E, Sugimachi K, Ikeda Y, Uchiyama H, Maeda T, Itoh S, Harimoto N, Ikegami T, Maehara Y.

Anticancer Res. 2016 May;36(5):2407-12.

PMID:
27127150
37.

Increased Copy Number of the Gene Encoding SF3B4 Indicates Poor Prognosis in Hepatocellular Carcinoma.

Iguchi T, Komatsu H, Masuda T, Nambara S, Kidogami S, Ogawa Y, Hu Q, Saito T, Hirata H, Sakimura S, Uchi R, Hayashi N, Ito S, Eguchi H, Sugimachi K, Maehara Y, Mimori K.

Anticancer Res. 2016 May;36(5):2139-44.

PMID:
27127115
38.

[Placement of An Expandable Metallic Stent for Malignant Tracheal Stenosis: A Case Report].

Ichiki Y, Kawasaki J, Yoshida T, Hamatsu T, Suehiro T, Tanaka F, Sugimachi K.

J UOEH. 2016 Mar 1;38(1):71-6. doi: 10.7888/juoeh.38.71. Japanese.

39.

Integrated Molecular Profiling of Human Gastric Cancer Identifies DDR2 as a Potential Regulator of Peritoneal Dissemination.

Kurashige J, Hasegawa T, Niida A, Sugimachi K, Deng N, Mima K, Uchi R, Sawada G, Takahashi Y, Eguchi H, Inomata M, Kitano S, Fukagawa T, Sasako M, Sasaki H, Sasaki S, Mori M, Yanagihara K, Baba H, Miyano S, Tan P, Mimori K.

Sci Rep. 2016 Mar 3;6:22371. doi: 10.1038/srep22371.

40.

Integrated Multiregional Analysis Proposing a New Model of Colorectal Cancer Evolution.

Uchi R, Takahashi Y, Niida A, Shimamura T, Hirata H, Sugimachi K, Sawada G, Iwaya T, Kurashige J, Shinden Y, Iguchi T, Eguchi H, Chiba K, Shiraishi Y, Nagae G, Yoshida K, Nagata Y, Haeno H, Yamamoto H, Ishii H, Doki Y, Iinuma H, Sasaki S, Nagayama S, Yamada K, Yachida S, Kato M, Shibata T, Oki E, Saeki H, Shirabe K, Oda Y, Maehara Y, Komune S, Mori M, Suzuki Y, Yamamoto K, Aburatani H, Ogawa S, Miyano S, Mimori K.

PLoS Genet. 2016 Feb 18;12(2):e1005778. doi: 10.1371/journal.pgen.1005778. eCollection 2016 Feb. Erratum in: PLoS Genet. 2017 May 19;13(5):e1006798.

41.

Genomic Landscape of Esophageal Squamous Cell Carcinoma in a Japanese Population.

Sawada G, Niida A, Uchi R, Hirata H, Shimamura T, Suzuki Y, Shiraishi Y, Chiba K, Imoto S, Takahashi Y, Iwaya T, Sudo T, Hayashi T, Takai H, Kawasaki Y, Matsukawa T, Eguchi H, Sugimachi K, Tanaka F, Suzuki H, Yamamoto K, Ishii H, Shimizu M, Yamazaki H, Yamazaki M, Tachimori Y, Kajiyama Y, Natsugoe S, Fujita H, Mafune K, Tanaka Y, Kelsell DP, Scott CA, Tsuji S, Yachida S, Shibata T, Sugano S, Doki Y, Akiyama T, Aburatani H, Ogawa S, Miyano S, Mori M, Mimori K.

Gastroenterology. 2016 May;150(5):1171-1182. doi: 10.1053/j.gastro.2016.01.035. Epub 2016 Feb 10.

42.

Clinical and biological significance of transcription termination factor, RNA polymerase I in human liver hepatocellular carcinoma.

Komatsu H, Iguchi T, Ueda M, Nambara S, Saito T, Hirata H, Sakimura S, Takano Y, Uchi R, Shinden Y, Eguchi H, Masuda T, Sugimachi K, Eguchi H, Doki Y, Mori M, Mimori K.

Oncol Rep. 2016 Apr;35(4):2073-80. doi: 10.3892/or.2016.4593. Epub 2016 Jan 25.

PMID:
26821084
43.

Relevance of microRNA-18a and microRNA-199a-5p to hepatocellular carcinoma recurrence after living donor liver transplantation.

Morita K, Shirabe K, Taketomi A, Soejima Y, Yoshizumi T, Uchiyama H, Ikegami T, Yamashita Y, Sugimachi K, Harimoto N, Itoh S, Ikeda T, Maehara Y.

Liver Transpl. 2016 May;22(5):665-76. doi: 10.1002/lt.24400.

44.

Dysregulated YAP1/TAZ and TGF-β signaling mediate hepatocarcinogenesis in Mob1a/1b-deficient mice.

Nishio M, Sugimachi K, Goto H, Wang J, Morikawa T, Miyachi Y, Takano Y, Hikasa H, Itoh T, Suzuki SO, Kurihara H, Aishima S, Leask A, Sasaki T, Nakano T, Nishina H, Nishikawa Y, Sekido Y, Nakao K, Shin-Ya K, Mimori K, Suzuki A.

Proc Natl Acad Sci U S A. 2016 Jan 5;113(1):E71-80. doi: 10.1073/pnas.1517188113. Epub 2015 Dec 22.

45.

Favorable Prognosis in Patients with Sustained Virological Response to Antiviral Therapy, Including Interferon, for Chronic Hepatitis C Before Hepatic Resection for Hepatocellular Carcinoma.

Shirabe K, Sugimachi K, Harada N, Kayashima H, Maeda T, Tsujita E, Minagawa R, Kajiyama K, Yoshiya S, Maehara Y.

Anticancer Res. 2015 Dec;35(12):6963-9.

PMID:
26637923
46.

An Integrative Analysis to Identify Driver Genes in Esophageal Squamous Cell Carcinoma.

Sawada G, Niida A, Hirata H, Komatsu H, Uchi R, Shimamura T, Takahashi Y, Kurashige J, Matsumura T, Ueo H, Takano Y, Ueda M, Sakimura S, Shinden Y, Eguchi H, Sudo T, Sugimachi K, Yamasaki M, Tanaka F, Tachimori Y, Kajiyama Y, Natsugoe S, Fujita H, Tanaka Y, Calin G, Miyano S, Doki Y, Mori M, Mimori K.

PLoS One. 2015 Oct 14;10(10):e0139808. doi: 10.1371/journal.pone.0139808. eCollection 2015.

47.

Identification of Recurrence-Related microRNAs from Bone Marrow in Hepatocellular Carcinoma Patients.

Sugimachi K, Sakimura S, Tomokuni A, Uchi R, Hirata H, Komatsu H, Shinden Y, Iguchi T, Eguchi H, Masuda T, Morita K, Shirabe K, Eguchi H, Maehara Y, Mori M, Mimori K.

J Clin Med. 2015 Aug 14;4(8):1600-11. doi: 10.3390/jcm4081600.

48.

miR-29b is an indicator of prognosis in breast cancer patients.

Shinden Y, Iguchi T, Akiyoshi S, Ueo H, Ueda M, Hirata H, Sakimura S, Uchi R, Takano Y, Eguchi H, Sugimachi K, Kijima Y, Natsugoe S, Mimori K.

Mol Clin Oncol. 2015 Jul;3(4):919-923. Epub 2015 May 12.

49.

Rapid intraoperative visualization of breast lesions with γ-glutamyl hydroxymethyl rhodamine green.

Ueo H, Shinden Y, Tobo T, Gamachi A, Udo M, Komatsu H, Nambara S, Saito T, Ueda M, Hirata H, Sakimura S, Takano Y, Uchi R, Kurashige J, Akiyoshi S, Iguchi T, Eguchi H, Sugimachi K, Kubota Y, Kai Y, Shibuta K, Kijima Y, Yoshinaka H, Natsugoe S, Mori M, Maehara Y, Sakabe M, Kamiya M, Kakareka JW, Pohida TJ, Choyke PL, Kobayashi H, Ueo H, Urano Y, Mimori K.

Sci Rep. 2015 Jul 13;5:12080. doi: 10.1038/srep12080.

50.

Exosomal microRNA in serum is a novel biomarker of recurrence in human colorectal cancer.

Matsumura T, Sugimachi K, Iinuma H, Takahashi Y, Kurashige J, Sawada G, Ueda M, Uchi R, Ueo H, Takano Y, Shinden Y, Eguchi H, Yamamoto H, Doki Y, Mori M, Ochiya T, Mimori K.

Br J Cancer. 2015 Jul 14;113(2):275-81. doi: 10.1038/bjc.2015.201. Epub 2015 Jun 9.

Supplemental Content

Loading ...
Support Center